| Print
IPSEN (IPN)
IPSENThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders. Over the past nearly 100 years, Ipsen has shifted its focus to specialty care, which comprises the vast majority of its total revenue. In February2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 25 drugs in 115 countries.
Address
65, quai Georges Gorse
Paris
FRA
92100
Telephone
+33 158335129
Forecast key dates
| Name | Key Date |
|---|---|
| Ipsen SA Second Quarter Earnings Conference Call for 2026 | 2026-07-31T13:00:00 |
| Ipsen SA Second Quarter Earnings Results for 2026 | 2026-07-31T07:00:00 |
| Ipsen SA Annual General Meeting for 2026 | 2026-05-21T00:00:00 |
| Ipsen SA Annual Report for 2025 | 2026-04-08T00:00:00 |
| Ipsen SA Fourth Quarter Earnings Conference Call for 2025 | 2026-02-13T13:00:00 |
| Ipsen SA Fourth Quarter Earnings Results for 2025 | 2026-02-13T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Ipsen SA Second Quarter Earnings Conference Call for 2025 | 2025-07-31T13:00:00 |
| Ipsen SA Second Quarter Earnings Results for 2025 | 2025-07-31T07:00:00 |
| Ipsen SA Annual General Meeting for 2025 | 2025-05-21T00:00:00 |
| Sales for the first quarter of 2025 | 2025-04-16T14:00:00 |
| Ipsen SA Annual Report for 2024 | 2025-04-08T00:00:00 |
| Ipsen SA Fourth Quarter Earnings Conference Call for 2024 | 2025-02-13T13:00:00 |
| Ipsen SA Fourth Quarter Earnings Result for 2024 | 2025-02-13T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.